cdi_labs Profile Banner
CDI Labs Profile
CDI Labs

@cdi_labs

Followers
3K
Following
344
Media
131
Statuses
296

CDI Labs is a specialized CRO and lab services proteomics company powered by cutting-edge synthetic biology platforms.

Mayagüez, PR | Baltimore, MD
Joined September 2014
Don't wanna be here? Send us removal request.
@cdi_labs
CDI Labs
3 days
We’re excited to celebrate (and maybe brag a little) about our impact on advancing research and empowering scientists to publish their groundbreaking studies in some of the world's most prestigious journals. With over 350+ high-profile papers citing our cutting-edge platforms and
0
0
2
@cdi_labs
CDI Labs
12 days
PRESS RELEASE: We’re excited to announce the launch of our comprehensive Pan-isotype Profiling and Analysis platform! This cutting-edge solution enables researchers to explore all isotypes and subclasses, including IgA, IgD, IgE, IgG, and IgM, providing deeper insights into
Tweet media one
0
0
1
@cdi_labs
CDI Labs
26 days
Decode murine autoantibodies like never before – profile over 50,000+ proteins from the entire mouse proteome in ONE assay. Our #MouseScan™ PhIP-Seq (Phage Display ImmunoPrecipitation Sequencing) platform enables researchers to uncover epitope-level insights into immune
Tweet media one
0
0
1
@cdi_labs
CDI Labs
27 days
In a paper published in Frontiers in Immunology, Lixin Zhang and colleagues at the University of Pittsburgh School of Medicine explore the complex role of B lymphocytes in the ovarian tumor microenvironment. Utilizing #HuProt's cutting-edge human proteome microarray, the
Tweet media one
0
0
1
@cdi_labs
CDI Labs
28 days
RT @seromics: ^^^ if you’d like to work on this we just built a pan-human peptide hormone PhIP-Seq library to find these @cdi_labs - surpri….
0
2
0
@cdi_labs
CDI Labs
1 month
PRESS RELEASE: We are thrilled to announce the launch of our innovative Peptide Hormone PhIP-Seq library, a groundbreaking advancement in identifying hormone-specific autoantibodies. This cutting-edge technology combines phage display with next-gen sequencing, enabling
Tweet media one
0
0
2
@cdi_labs
CDI Labs
1 month
In this insightful blog by Shaohui Hu, Wendy Yap and Shuang Liu, we explore the history and innovation of #HuProt™, the world’s largest, most comprehensive protein microarray. Representing over 81% of the human proteome, HuProt revolutionizes the study of protein functions and
Tweet media one
0
0
1
@cdi_labs
CDI Labs
1 month
Unlock the secrets of the human immune system with #VirScan® PHIP-Seq, the cutting-edge platform revolutionizing pathogen detection and immune profiling. Powered by Phage Display ImmunoPrecipitation Sequencing (PHIP-Seq), VirScan takes immune analysis to the next level. By
Tweet media one
0
0
1
@cdi_labs
CDI Labs
2 months
CDI Labs at #FOCIS2025! Join us tomorrow, June 26, at 7:30 PM (Poster # Th189), for an exciting poster session titled, "Seromic Atlas of APS-1 Syndrome." Presented by Tyler Hulett, PhD, this session will delve into groundbreaking advances in the use of synthetic biology tools for
Tweet media one
0
2
4
@cdi_labs
CDI Labs
2 months
RT @seromics: My guess is nobody can agree on what diet is best for weight loss because a shocking percentage of the population is developi….
0
1
0
@cdi_labs
CDI Labs
2 months
Next week we're in Boston for #FOCIS2025! Visit us at Booth 2 to learn how our groundbreaking technologies and industry-leading lab services are transforming research in immune-mediated diseases. We’re empowering researchers to deepen their understanding of autoimmune diseases
Tweet media one
0
0
1
@cdi_labs
CDI Labs
2 months
Our innovative #VirD™ Membrane Protein Microarray platform revolutionizes biologics screening by enabling high-precision analysis of interactions with membrane proteins. VirD consists of HSV-1 virions which are engineered to display membrane-embedded proteins of interest with
Tweet media one
0
0
3
@cdi_labs
CDI Labs
2 months
As presented at Immunology 2025, Matthieu Roulleaux Dugage (Gustave Roussy) and his team unveiled an important predictive biomarker for immunotherapy response in patients with advanced non-small cell lung cancer (NSCLC): baseline serum levels of immunoglobulin G (IgG) targeting
Tweet media one
0
0
0